"Designing Growth Strategies is in our DNA"

Artificial Intelligence in Genomics Market Size, Share, and COVID-19 Impact Analysis By Offering (Software and Services), By Delivery Mode (On Cloud and Premise), By Technology (Machine Learning and Computer Vision), By Application (Diagnostics, Drug Discovery & Development, and Precision Medicine), and By End-User (Pharmaceutical and Biotechnology Companies, Research Institutes, and Others), and Regional Forecast, 2024-2032

Published On : July 13, 2023 | Report ID: FBI107737 | Status : Ongoing

 

KEY MARKET INSIGHTS

Artificial intelligence (AI) was developed to perform tasks that would generally require human intelligence. However, the technology currently has opened new growth avenues in the field of healthcare, such as clinical genomics. Through deep learning and machine learning, artificial intelligence is used to process large and complex genomic datasets. Although the use of AI and ML in genomics is in the early stage, the advantages associated such as accurate identification of genetic disorders, identification of the primary kind of cancer through liquid biopsy, and mapping the progress of cancer in individuals is expected to drive the growth of the market.


Furthermore, the adoption of AI solutions in the development of precision medicine, the increasing investment by major companies in the research and development of AI in genomics, and the growing government initiatives are fueling the market growth.


  • For instance, in July 2022, CSIR Institute of Genomics and Integrative Biology in India partnered with Lenovo in order to accelerate cancer-related research by using Lenovo Genomics Optimization and Scalability Tool (GOAST).


Impact of COVID-19 on Artificial Intelligence in Genomics Market 


The covid-19 pandemic created significant opportunities for AI in genomics for drug discovery, development, and diagnostics. AI in genomics helped in the identification of the SARS-CoV-2 sequence during the pandemic. Furthermore, it also helped in the identification of the variants such as delta strains and omicron. Technologies such as bioinformatics, immune informatics, machine learning, and reverse vaccinology were used in the development of drugs and vaccines used for the treatment of the SARS-CoV-2 virus.

As the COVID-19 pandemic became a public health crisis, government regulatory bodies also partnered and collaborated with research institutes for assistance in COVID-19-related research.

The growing number of applications for AI in genomics during the pandemic has provided new growth avenues for the market.


  • For instance, in March 2020, Predictive Oncology and Soluble Therapeutics signed an agreement to launch an artificial intelligence platform for the development of vaccines and drug development during the COVID-19 pandem


Key Insights: 



  • New Product launches, By Key Players.

  • Key Industry developments- Partnerships, Mergers, and Acquisitions.

  • Overview: Technological Advancements in the AI in Genomics Market.

  • Overview: Developments related to Funding Received by Key Players.

  • Overview: Genomic Services.

  • Impact of COVID-19 on AI in Genomics Market.


Analysis by End User:


Based on End User, the market is bifurcated into pharmaceutical and biotechnology companies, research institutes and others. Pharmaceutical and Biotechnology companies holds the largest segment in the market. These companies are currently adoption AI in genomics for drug discovery and development of precision medicine as it accelerates the drug discovery process by reducing the turnaround time. Furthermore, the increasing demand for innovative medicines for genetic disorders and infectious diseases positively effects the market growth.


  • For instance, in October 2022, Illumina, Inc. and AstraZeneca plc signed an agreement to accelerate drug target discovery with the use of AI and genomics analysis technique. Based on the agreement the companies aim to find promising drugs based on human omics insights.


Therefore, the application of AI in genomics during the drug discovery process reduces the operational cost and increases efficiency during drug manufacturing.

Regional Analysis: 


To gain extensive insights into the market, Request for Customization


North-America market holds the largest share in the market due to the increasing initiatives by government and research organizations to promote AI in genomics for the development of precision medicine. Furthermore, the presence of major companies in the region also contributes towards the growth and the increasing strategic initiatives like collaboration and partnership with pharmaceutical companies contribute towards positive market growth


  • For instance, in November 2020, BioMarin Pharmaceutical Inc. and Deep Genomics announced a preclinical collaboration to use Deep Genomic’s AI drug discovery platform (The AI workbench) to identify oligonucleotides drug candidates for four rare diseases indication with high unmet needs.


Asia Pacific region is expected to witness lucrative growth due to the increasing integration of AI in genomics in countries like China and India. Furthermore, growing research initiatives and the developing infrastructure for genomic research also fuel the growth of the region in this market.


  • For instance, in June 2022, C2i Genomics, a cancer research company announced a strategic partnership with Karkinos Healthcare to co-develop the minimal residual disease (MRD) market in India.


Key Players:


The report will include the profiles of key players such as IBM, Verge Genomics, Microsoft, DEEP GENOMICS, Fabric Genomics, Inc., Predictive Oncology, Illumina, Inc., DNAnexus, Inc., Emedgene, and other prominent players.

Segmentation:






















By Offering


By Technology


By Application


By Delivery Mode


By End User


By Geography



  • Software

  • Services




  • Machine Learning

  • Computer Vision




  • Diagnostics

  • Drug Discovery & Development

  • Precision Medicine




  • On-premise

  • Cloud




  • Pharmaceutical and Biotechnology Companies

  • Research Institutes

  • Others




  • North America (U.S. and Canada)

  • Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)

  • Asia Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of APAC)

  • Latin America (Brazil, Mexico, and Rest of LATAM)

  • Middle East & Africa (GCC, South Africa, and Rest of MEA)



Key Industry Developments:



  • March 2022: Fabric Genomics, Inc. announced a partnership with the Broad Institute of MIT and Harvard in order to improve their whole genome sequencing (WGS) analysis offering.

  • September 2022: DNAnexus Inc. announced a three-year contract with Our Future Health to analyze the company’s biomedical dataset and provide tools to drive biological insights and global collaboration in order to advance precision medicine.

  • December 2020: Emedgene announced a non-exclusive partnership with Illumina, Inc. and the integration of automated interpretation into Illumina’s TruSight Software Suite for rare genetic diseases.





  • Ongoing
  • 2023
  • 2019-2022

Personalize this Research

  • Granular Research on Specified Regions or Segments
  • Companies Profiled based on User Requirement
  • Broader Insights Pertaining to a Specific Segment or Region
  • Breaking Down Competitive Landscape as per Your Requirement
  • Other Specific Requirement on Customization
Request Customization Banner

Healthcare Clients

Fresenius
Johnson
Siemens Healthineers
Roche
Styker

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X